Clinical phenotyping of children with SAVI has revealed three dominant gain‐of‐function mutations in exon 5 of the STING (TMEM173) gene,100 identifying key amino acids in STING‐involved regulation of type I IFN signaling. Here, STING1 is linked to STING-associated vasculopathy with onset in infancy.